Press Releases
 October
30,
2007 -- SGS announces that its Life Science
Services division has selected Vitalea Science as a partner for providing
Microdosing studies based on the Accelerator Mass Spectrometry (AMS)
technology. This partnership further strengthens the complementary services
offered by both SGS and Vitalea in executing early clinical trials based on
the exploratory-IND concept.
.
read more
August 24,
2007 --Vitalea Science, Inc., a privately held company that specializes in
microdosing and micro-tracing studies using AMS, announced today that it has
formed an alliance with the Division of Neonatology of Loma Linda University
to support clinical research studies on neonatal pharmacology.....
read more
June 12,
2007 -- Vitalea Science announces the completion of a dermal distribution
microdosing study assessing important ADME properties of a test compound
being explored for a variety of health indications. The study was conducted
at a global CRO's clinical research ... read more
May 16,
2007: Vitalea Science Expands its Scientific Advisory Board, Expands
Microdosing to Environmental Fate and Metabolism of Agricultural and
Industrial Chemicals Dr. Luis Ruzo of PTRL West joins the Scientific
Advisory Board (SAB) of Vitalea Science ... read more
 May 10,
2007: Vitalea Science Announces Key Addition to its Scientific Advisory Board
in Microdosing for Pediatric Pharmacology and HIV Research. Vitalea Science
announces the addition of Dr. Edmund Capparelli to its Scientific Advisory
Board. Dr. Capparelli is a leading HIV and pediatric ... read
more
February 15, 2007: New Tools Developed
by Vitalea Science for Pediatric Pharmacology Use Microdose a Accelerator
Mass Spectrometry ...
read more
January 29, 2007: Vitalea Science, Inc.
Announced Grant Award for Phase-I Development of a Diagnostic Test Utilizing
Accelerator Mass Spectrometry and Microdosing ...
read more
September
12, 2006: Vitalea Science and Paul Scherrer Institute (PSI) Announce a
Technological Alliance that will Eliminate Hazardous Radiation from
Pharmaceutical Studies ... read more
February 4,
2006: Vitalea Science, a Pioneer in Biological Accelerator Mass Spectrometry,
Completes Formation of Founding Scientific Advisory
Board ... read
more
October 22,
2005: Vitalea Science Pioneers "Accelerator Technology" for
HIV-Drug Testing: Results from First Microdose Study of the Antiretroviral AZT Released ... read more
June 8,
2005: First Human Microdosing Study of an anti-HIV compound carried out in
the US by Vitalea Science, Inc... read more
November
14, 2004 : When Physics and Nutrition Collide: Vitalea Science Demystifies
the Pharmacology of Nutraceuticals and Functional Foods Using Accelerator
Mass Spectrometry... read more
October 19,
2004 : Vitalea Science, Inc. offers calcium-41/Accelerator Mass Spectrometry
services for drug efficacy studies in the treatment of osteoporosis... read more
July 15,
2004 : Vitalea Science Offers Microdose Services – A Concept That Improves
Drug Development and Serves as Alternative to Animal Testing .. read more
June 23,
2004 : Vitalea Enables Exploratory AMS-Microdose Reducing The Cost Of Drug
Candidate Selection .. read
more
May 18,
2004 : Lawrence Livermore National Laboratory signed a license with Vitalea
Science, Inc. for the Accelerator Mass Spectrometry (AMS) for Biomedical and Pharmaceutical Applications
|
